Security readout for executives and security teams
This vulnerability affects Philips Vue imaging products and relates to improper validation of structured messages or data. A network-based attacker may be able to influence how data is processed, but the CVSS data indicates user interaction is required and availability impact is not identified. Most relevant to healthcare environments using Philips Vue PACS or related Vue components. Exposure depends on deployed product versions and whether systems process upstream or downstream structured data paths described by the CVE. Treat this as a moderate healthcare technology risk. It affects clinical imaging software, but the provided evidence does not show known exploitation, critical severity, or availability loss. Confirm exposure and vendor remediation status promptly. Mitigation focus: Check Philips product security guidance for affected versions and remediation status.; Review CISA ICSMA-21-187-01 before changing production medical imaging systems.; Inventory Philips Vue PACS, MyVue, Speech, and Motion deployments..
Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.
Conservative CVE-to-ATT&CK context
These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.
ATT&CK lookup starting points
Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.
CWE-707: Exact CWE lookup
Use the exact CWE identifier as the starting point before reviewing related ATT&CK behavior. Open the exact CWE lookup page first, then review the ATT&CK searches from that MITRE weakness context. This is a Glexia lookup hint, not an official ATT&CK mapping.
Open ATT&CK lookupCVE-2021-27493 mapping review
Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.
Open ATT&CK lookup- Severity
- Medium
- CVSS
- 6.1 (3.1)
- Known Exploited
- No
- Published
Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
CNA and ADP enrichment extracted from CVE v5
These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.
CVSS vector scores
1 official scoreWe collect every scored CVSS vector available in the official CNA and ADP containers. When more than one version is present, the table keeps the source vectors side by side instead of collapsing them into the highest score.
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N2.82.7Primary CVE scoreVulnerability scoring details
Base CVSS 3.1 score
6.1MediumVector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
Source materials
- CVE List V5 sourceCVE List V5
- https://www.cisa.gov/uscert/ics/advisories/icsma-21-187-01CVE reference · x_refsource_CONFIRM
Products and packages named in the record
CWE details
CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.
Improper Neutralization
Improper Neutralization represents a recurring weakness pattern that can create exploitable paths when design, validation, or implementation controls are missing.